Change of Adviser

RNS Number : 0892T

Integumen PLC

18 March 2019

 

18 March 2019

Integumen PLC

("Integumen" or "Company")

Change of Adviser

Integumen announces that it has reappointed Turner Pope Investments (TPI) Limited as broker to the Company with immediate effect.

Contacts

Integumen plc	Gerard Brandon, CEO	[phone]
SPARK Advisory Partners Limited (Nominated Adviser)	Neil Baldwin/Andrew Emmott	[phone]
Turner Pope Investments (TPI) Limited  (Broker)	Andy Thacker	[phone]

About Integumen:

Integumen is a vertically integrated business, collaborating their Labskin technology platform with partners in artificial intelligence, clinical research, medical device and life science. These collaborators are building their own technology on top of the Labskin AI backbone. Labskin allows skin-care, health-care, pharmaceutical manufacturers and cosmetic companies to test their products on human-like skin in a real-world environment with full access to multiple state-of-the-art partner technologies.

The Company combines data analytics with access to therapeutic operational expertise and offers solutions to our clients, from regulatory approvals, right through to marketing fully tested ingredients that have been certified on our Laboratory grown living human tissue.

 

END

 

 

APPJAMRTMBABBLL